are with the School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
are with the Department of Physical Medicine and Rehabilitation, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan.
Nutr Rev. 2023 Mar 10;81(4):397-415. doi: 10.1093/nutrit/nuac060.
Conjugated linoleic acid (CLA) has been reported to have anti-obesity and antidiabetic effects. However, the benefits of CLA combined with exercise remain unclear, and studies report conflicting results.
A systematic review and meta-analysis were performed to investigate the synergistic effect of CLA and exercise on body composition, exercise-related indices, insulin resistance, and lipid profiles; and of the safety of CLA supplements.
In October 2021, the PubMed, Embase, and Cochrane Library databases were searched for reports on clinical trials of the combined intervention of CLA and exercise.
A total of 18 randomized controlled trials and 2 crossover trials were included. The methodological quality assessment was performed using the revised Cochrane risk-of-bias tool. Pooled effect sizes were reported as standardized mean difference (SMD) for continuous data and risk ratio for dichotomous data with their corresponding 95% confidence intervals (CIs). Heterogeneity was tested using the I2 statistic.
The combination of CLA and exercise resulted in significantly decreased body fat (SMD, -0.42 [95%CI, -0.70, -0.14]; P = 0.003; I2 = 65) and insulin resistance (SMD, -0.25 [95%CI, -0.44, -0.06]; P = 0.01; I2 = 0) than did exercise alone. In subgroup analysis, the following factors were associated with significant outcomes: (1) body mass index ≥25 kg/m2; (2) female sex; (3) follow-up time >4 weeks; and (4) intervention duration >4 weeks. Nevertheless, supplementation with CLA during exercise programs was not effective for body-weight control, exercise performance enhancement, or lipid-profile improvement. CLA in combination with exercise did not result in a higher risk of adverse events (risk ratio, 1.32 [95%CI, 0.94-1.84]; P > 0.05; I2 = 0).
CLA combined with exercise is generally safe and can lower body fat and insulin resistance but does not reduce body weight, enhance exercise performance, or improve lipid profiles.
共轭亚油酸(CLA)已被报道具有抗肥胖和抗糖尿病的作用。然而,CLA 与运动相结合的益处尚不清楚,并且研究报告的结果相互矛盾。
进行系统评价和荟萃分析,以调查 CLA 和运动联合干预对身体成分、与运动相关的指标、胰岛素抵抗和血脂谱的协同作用,以及 CLA 补充剂的安全性。
2021 年 10 月,检索 PubMed、Embase 和 Cochrane 图书馆数据库,查找关于 CLA 和运动联合干预的临床试验报告。
共纳入 18 项随机对照试验和 2 项交叉试验。使用修订后的 Cochrane 偏倚风险工具进行方法学质量评估。连续数据的汇总效应大小以标准化均数差(SMD)报告,二分类数据以风险比及其相应的 95%置信区间(CI)报告。使用 I2 统计量检验异质性。
与单独运动相比,CLA 和运动的联合使用可显著降低体脂(SMD,-0.42 [95%CI,-0.70,-0.14];P=0.003;I2=65)和胰岛素抵抗(SMD,-0.25 [95%CI,-0.44,-0.06];P=0.01;I2=0)。在亚组分析中,以下因素与显著结果相关:(1)体重指数≥25kg/m2;(2)女性;(3)随访时间>4 周;(4)干预时间>4 周。然而,在运动计划中补充 CLA 对控制体重、提高运动表现或改善血脂谱没有效果。CLA 与运动联合使用不会增加不良事件的风险(风险比,1.32 [95%CI,0.94-1.84];P>0.05;I2=0)。
CLA 与运动联合使用通常是安全的,可以降低体脂和胰岛素抵抗,但不能降低体重、提高运动表现或改善血脂谱。